193 results
Page 7 of 10
8-K
EX-99.1
5ajd jw58lo0kf
2 Jul 20
Moleculin Provides Update on Annamycin Clinical Development
7:32am
8-K
EX-99.1
0f4uy98z
1 Jul 20
New Publication Finds Combination of WP1066 and Radiation Resulted in Long-Term Survival in Human Brain Tumor Mouse Model
7:31am
8-K
EX-99.1
81le3inkj1
25 Jun 20
Moleculin Announces Preclinical Data Confirms Efficacy of Annamycin in Lung Metastases
7:31am
8-K
EX-99.1
pxzjjp
16 Jun 20
Moleculin Announces Confirmatory In Vitro Analysis of WP1122
7:32am
8-K
EX-99.1
57wcold7u2004p1s
28 May 20
Moleculin Announces Common Stock
7:30am
8-K
EX-99.1
e2k5gaip9224k1xcy
27 May 20
Moleculin Provides Update on Coronavirus Drug Development
5:20pm
8-K
EX-99.1
6goukgoio6rek a2f
18 May 20
Moleculin Announces Nasdaq Trading Halt Pending Receipt of Additional Information
4:01pm
8-K
EX-99.1
ukl4ozct bh91kf
11 May 20
Regulation FD Disclosure
7:31am
DEFA14A
xqjss8x9dc
8 May 20
Additional proxy soliciting materials
7:31am
8-K
EX-99.1
y4ay8j3k
22 Apr 20
Moleculin Announces Head of NIAID Antiviral Drug Discovery and Development Center Joins COVID-19 Drug Development Team
7:30am
8-K
EX-99.1
6tmxxdyxo
15 Apr 20
Moleculin Announces Leading Virologist Joins Development Team
7:30am
8-K
EX-99.1
5rlz3zs57o
14 Apr 20
Moleculin Announces Investor Conference Call to Discuss COVID-19 Potential for Drug Candidate
7:30am
8-K
EX-99.1
o8d25fb6bfauy xm
8 Apr 20
Other Events
7:30am
8-K
EX-99.1
5uad0w 4zep
2 Apr 20
Moleculin Announces Additional Positive Safety Data in EU AML Trial
7:30am
8-K
EX-99.1
9ozpcjijy
19 Mar 20
Results of Operations and Financial Condition
4:16pm
8-K
EX-99.1
cdqppc17sv9toh
17 Mar 20
Moleculin Signs Agreement with UTMB to Test WP1122 on a Range of Viruses, including Coronavirus
7:31am
8-K
EX-99.1
mq5flh08f pwe
10 Mar 20
Moleculin Announces Dr. Hongbo Zhai Joins Science Advisory Board
7:31am
8-K
EX-99.1
htsm hx0r
4 Mar 20
Moleculin Issues Video Shareholder Letter
7:31am